About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Biochemistry
›
top-articles
Biochemistry
Royal Free Hospital
807
(top 1%)
papers
34.7K
(top 1%)
citations
100
(top 1%)
h
-index
158
(top 1%)
g
-index
1.0K
all documents
41.9K
doc citations
5.4K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Journal of Clinical Oncology
2010
724
2
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation
Atherosclerosis
2015
613
3
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Lancet, The
2010
612
4
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Journal of Clinical Endocrinology and Metabolism
2009
527
5
Rho and Rac but not Cdc42 regulate endothelial cell permeability
Journal of Cell Science
2001
412
6
Adiponectin and Coronary Heart Disease
Circulation
2006
397
7
Non-alcoholic fatty liver disease and dyslipidemia: An update
Metabolism: Clinical and Experimental
2016
397
8
Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Archives of Medical Science
2015
318
9
Shear stress–induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases
Journal of Cell Biology
2003
314
10
Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation
Nutrition Reviews
2017
313
11
Orlistat-Associated Adverse Effects and Drug Interactions
Drug Safety
2008
306
12
Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension
European Heart Journal
2006
286
13
RhoE Binds to ROCK I and Inhibits Downstream Signaling
Molecular and Cellular Biology
2003
280
14
Ezrin/radixin/moesin proteins and Rho GTPase signalling in leucocytes
Immunology
2004
270
15
Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2
American Journal of Physiology - Lung Cellular and Molecular Physiology
2000
254
16
Platelets as Predictors of Vascular Risk: Is There a Practical Index of Platelet Activity?
Clinical and Applied Thrombosis/Hemostasis
2003
254
17
Lysosomal acid lipase deficiency – An under-recognized cause of dyslipidaemia and liver dysfunction
Atherosclerosis
2014
248
18
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Nutrition Reviews
2017
246
19
Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy
Annals of Neurology
2000
245
20
Cyclooxygenase-2 Deficiency Results in a Loss of the Anti-Proliferative Response to Transforming Growth Factor-β in Human Fibrotic Lung Fibroblasts and Promotes Bleomycin-Induced Pulmonary Fibrosis in Mice
American Journal of Pathology
2001
241
21
Nramp2 Expression Is Associated with pH-dependent Iron Uptake across the Apical Membrane of Human Intestinal Caco-2 Cells
Journal of Biological Chemistry
2000
238
22
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
Current Medical Research and Opinion
2006
238
23
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
Metabolism: Clinical and Experimental
2006
236
24
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the greek atorvastatin and coronary-heart-disease evaluation (GREACE) study
American Journal of Kidney Diseases
2004
226
25
Roles of Rho/ROCK and MLCK in TNF-α-induced changes in endothelial morphology and permeability
Journal of Cellular Physiology
2007
221
26
Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Journal of the American Heart Association
2016
221
27
The Role of Nutraceuticals in Statin Intolerant Patients
Journal of the American College of Cardiology
2018
221
28
Leptin, cardiovascular diseases and type 2 diabetes mellitus
Acta Pharmacologica Sinica
2018
217
29
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
Metabolism: Clinical and Experimental
2017
216
30
Elevated heart rate and atherosclerosis: An overview of the pathogenetic mechanisms
International Journal of Cardiology
2008
214
31
Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Archives of Medical Science
2017
213
32
The fab and fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling 1 1Edited by R. Huber
Journal of Molecular Biology
1999
210
33
Effect of hepcidin on intestinal iron absorption in mice
Blood
2004
199
34
Terminal Transferase-Positive Human Bone Marrow Cells Exhibit the Antigenic Phenotype of Common Acute Lymphoblastic Leukemia
Journal of Immunology
1979
196
35
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV
*
HIV Medicine
2008
192
36
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Current Vascular Pharmacology
2011
190
37
Angiotensin II Is Mitogenic for Human Lung Fibroblasts via Activation of the Type 1 Receptor
American Journal of Respiratory and Critical Care Medicine
2000
186
38
PI3-kinase inhibition: a target for drug development?
Trends in Molecular Medicine
2000
184
39
Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine
Gut
2000
183
40
Direct Thrombin Inhibition Reduces Lung Collagen, Accumulation, and Connective Tissue Growth Factor mRNA Levels in Bleomycin-Induced Pulmonary Fibrosis
American Journal of Pathology
2001
179
41
Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies
BMC Medicine
2015
177
42
Effects of Coenzyme Q10 on Statin-Induced Myopathy
Mayo Clinic Proceedings
2015
175
43
Rho Proteins and Cancer
Breast Cancer Research and Treatment
2004
174
44
The role of Toll-like receptors in renal diseases
Nature Reviews Nephrology
2010
169
45
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions
Current Medical Research and Opinion
2005
167
46
Lipid-modifying effects of nutraceuticals: An evidence-based approach
Nutrition
2016
162
47
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study
Nephrology Dialysis Transplantation
2006
160
48
Early vascular benefits of statin therapy
Current Medical Research and Opinion
2003
159
49
Statin-fibrate combination therapy for hyperlipidaemia: a review
Current Medical Research and Opinion
2003
158
50
Analysis of vitamin D levels in patients with and without statin-associated myalgia — A systematic review and meta-analysis of 7 studies with 2420 patients
International Journal of Cardiology
2015
157
site/software ©
exaly
; All materials licenced under
CC by-SA
.